Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Viral Envelope Proteins | 8 | 2025 | 103 | 3.780 |
Why?
|
| Virus Internalization | 14 | 2025 | 88 | 3.490 |
Why?
|
| Ebolavirus | 6 | 2025 | 39 | 3.350 |
Why?
|
| HIV-1 | 14 | 2024 | 721 | 3.020 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 8 | 2024 | 56 | 2.710 |
Why?
|
| Protein Conformation | 17 | 2025 | 779 | 2.290 |
Why?
|
| Fluorescence Resonance Energy Transfer | 18 | 2025 | 79 | 2.250 |
Why?
|
| Membrane Fusion | 8 | 2025 | 68 | 2.030 |
Why?
|
| Spike Glycoprotein, Coronavirus | 6 | 2024 | 113 | 1.980 |
Why?
|
| Hemorrhagic Fever, Ebola | 4 | 2025 | 29 | 1.960 |
Why?
|
| Ribosomes | 10 | 2011 | 163 | 1.870 |
Why?
|
| HIV Antibodies | 7 | 2024 | 146 | 1.620 |
Why?
|
| Virion | 8 | 2025 | 121 | 1.260 |
Why?
|
| Protein Binding | 10 | 2025 | 1603 | 1.250 |
Why?
|
| HIV Envelope Protein gp120 | 6 | 2018 | 133 | 1.240 |
Why?
|
| Protein Multimerization | 8 | 2024 | 176 | 1.230 |
Why?
|
| Single Molecule Imaging | 5 | 2024 | 22 | 1.140 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2025 | 48 | 1.070 |
Why?
|
| CD4 Antigens | 8 | 2024 | 149 | 1.020 |
Why?
|
| Protein Biosynthesis | 5 | 2010 | 320 | 0.900 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2024 | 26 | 0.830 |
Why?
|
| RNA, Transfer | 7 | 2019 | 89 | 0.810 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2025 | 41 | 0.790 |
Why?
|
| 5' Untranslated Regions | 2 | 2021 | 29 | 0.790 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2025 | 120 | 0.740 |
Why?
|
| Nucleic Acid Conformation | 7 | 2021 | 239 | 0.740 |
Why?
|
| HIV Envelope Protein gp41 | 3 | 2020 | 28 | 0.730 |
Why?
|
| HIV Infections | 7 | 2024 | 969 | 0.730 |
Why?
|
| Antibodies, Neutralizing | 8 | 2024 | 209 | 0.720 |
Why?
|
| RNA, Viral | 2 | 2021 | 276 | 0.710 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2024 | 458 | 0.710 |
Why?
|
| Influenza A virus | 2 | 2022 | 123 | 0.700 |
Why?
|
| HEK293 Cells | 9 | 2021 | 622 | 0.700 |
Why?
|
| Lassa virus | 1 | 2020 | 5 | 0.670 |
Why?
|
| Acids | 1 | 2020 | 14 | 0.670 |
Why?
|
| Peptide Elongation Factor G | 2 | 2010 | 9 | 0.660 |
Why?
|
| Glycoproteins | 2 | 2023 | 187 | 0.610 |
Why?
|
| Protein Domains | 4 | 2024 | 149 | 0.590 |
Why?
|
| Optical Imaging | 1 | 2019 | 71 | 0.580 |
Why?
|
| Genome, Viral | 1 | 2019 | 136 | 0.570 |
Why?
|
| Virus Assembly | 2 | 2019 | 53 | 0.570 |
Why?
|
| Lipids | 1 | 2020 | 315 | 0.560 |
Why?
|
| Escherichia coli | 4 | 2011 | 707 | 0.550 |
Why?
|
| Cell Membrane | 2 | 2024 | 496 | 0.530 |
Why?
|
| Humans | 36 | 2025 | 63443 | 0.500 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2024 | 641 | 0.500 |
Why?
|
| Influenza, Human | 1 | 2018 | 208 | 0.480 |
Why?
|
| RNA, Messenger | 3 | 2011 | 1537 | 0.470 |
Why?
|
| Models, Molecular | 12 | 2024 | 1149 | 0.470 |
Why?
|
| Protein Structure, Quaternary | 2 | 2014 | 100 | 0.460 |
Why?
|
| Immune Evasion | 2 | 2014 | 68 | 0.450 |
Why?
|
| Negotiating | 1 | 2014 | 15 | 0.450 |
Why?
|
| RNA, Transfer, Amino Acyl | 3 | 2011 | 9 | 0.440 |
Why?
|
| Thermodynamics | 3 | 2009 | 196 | 0.430 |
Why?
|
| Allosteric Regulation | 3 | 2024 | 69 | 0.430 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 38 | 0.420 |
Why?
|
| Binding Sites | 6 | 2024 | 905 | 0.410 |
Why?
|
| Epitopes | 3 | 2024 | 290 | 0.360 |
Why?
|
| Endosomes | 2 | 2023 | 177 | 0.340 |
Why?
|
| Nucleocapsid | 2 | 2021 | 12 | 0.340 |
Why?
|
| Calcium | 3 | 2024 | 575 | 0.330 |
Why?
|
| Microscopy | 2 | 2021 | 91 | 0.310 |
Why?
|
| AIDS Vaccines | 3 | 2018 | 71 | 0.280 |
Why?
|
| Genomics | 2 | 2021 | 370 | 0.270 |
Why?
|
| Kinetics | 6 | 2014 | 763 | 0.260 |
Why?
|
| Dimerization | 2 | 2019 | 145 | 0.260 |
Why?
|
| Mutation | 6 | 2025 | 2612 | 0.250 |
Why?
|
| Virus Attachment | 1 | 2024 | 18 | 0.220 |
Why?
|
| Proteins | 1 | 2009 | 750 | 0.210 |
Why?
|
| Antibodies, Viral | 3 | 2021 | 327 | 0.210 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2023 | 29 | 0.200 |
Why?
|
| Hemagglutinins | 2 | 2022 | 17 | 0.200 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2023 | 86 | 0.190 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2023 | 53 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 673 | 0.190 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2021 | 25 | 0.170 |
Why?
|
| Polysaccharides | 2 | 2020 | 144 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 149 | 0.170 |
Why?
|
| Vero Cells | 1 | 2020 | 80 | 0.170 |
Why?
|
| RNA, Bacterial | 2 | 2011 | 74 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 337 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 669 | 0.160 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 54 | 0.160 |
Why?
|
| Base Pairing | 1 | 2019 | 45 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 248 | 0.150 |
Why?
|
| A549 Cells | 1 | 2018 | 39 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.140 |
Why?
|
| Ribosomal Proteins | 2 | 2009 | 43 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2157 | 0.140 |
Why?
|
| RNA Stability | 2 | 2009 | 102 | 0.140 |
Why?
|
| Polymers | 1 | 2021 | 325 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 504 | 0.140 |
Why?
|
| Virus Replication | 1 | 2019 | 321 | 0.140 |
Why?
|
| Cryoelectron Microscopy | 4 | 2025 | 200 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 373 | 0.130 |
Why?
|
| Mutant Proteins | 1 | 2016 | 105 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 301 | 0.120 |
Why?
|
| Animals | 8 | 2022 | 20663 | 0.120 |
Why?
|
| Protein Stability | 2 | 2019 | 92 | 0.120 |
Why?
|
| Focal Adhesions | 1 | 2014 | 24 | 0.110 |
Why?
|
| Histocompatibility Antigens | 1 | 2014 | 105 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2014 | 48 | 0.110 |
Why?
|
| Models, Chemical | 1 | 2014 | 139 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2014 | 94 | 0.110 |
Why?
|
| RNA, Transfer, Met | 2 | 2010 | 2 | 0.100 |
Why?
|
| Ligands | 1 | 2014 | 416 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 242 | 0.100 |
Why?
|
| HIV Protease Inhibitors | 1 | 2014 | 105 | 0.100 |
Why?
|
| Virus Release | 1 | 2012 | 14 | 0.100 |
Why?
|
| Macromolecular Substances | 2 | 2010 | 160 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 209 | 0.100 |
Why?
|
| Receptors, Virus | 2 | 2023 | 73 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2009 | 98 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2014 | 707 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2010 | 260 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2009 | 173 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2009 | 60 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 489 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2009 | 245 | 0.070 |
Why?
|
| Puromycin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2022 | 895 | 0.070 |
Why?
|
| Acylation | 1 | 2007 | 16 | 0.070 |
Why?
|
| RNA Transport | 1 | 2007 | 31 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2007 | 56 | 0.060 |
Why?
|
| Models, Biological | 4 | 2016 | 1180 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2018 | 166 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2008 | 477 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2007 | 309 | 0.060 |
Why?
|
| Cell Line | 2 | 2022 | 2040 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2020 | 383 | 0.060 |
Why?
|
| Electron Microscope Tomography | 1 | 2025 | 15 | 0.060 |
Why?
|
| Bacteriophage T4 | 1 | 2003 | 7 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 433 | 0.050 |
Why?
|
| Detergents | 1 | 2023 | 34 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 574 | 0.050 |
Why?
|
| Leukemia Virus, Murine | 1 | 2022 | 30 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2023 | 115 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 263 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2023 | 276 | 0.040 |
Why?
|
| Click Chemistry | 1 | 2021 | 9 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 70 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 45 | 0.040 |
Why?
|
| Herpesvirus 1, Human | 1 | 2021 | 82 | 0.040 |
Why?
|
| Species Specificity | 1 | 2020 | 334 | 0.040 |
Why?
|
| Equipment Design | 1 | 2021 | 352 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 167 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2021 | 536 | 0.040 |
Why?
|
| Hydrogels | 1 | 2021 | 115 | 0.040 |
Why?
|
| Disulfides | 1 | 2019 | 64 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 263 | 0.040 |
Why?
|
| Cattle | 1 | 2019 | 310 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1277 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 209 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 658 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 223 | 0.030 |
Why?
|
| Hydrolysis | 2 | 2010 | 144 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 864 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 671 | 0.030 |
Why?
|
| Mice | 2 | 2022 | 10844 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2014 | 20 | 0.030 |
Why?
|
| Paxillin | 1 | 2014 | 9 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 138 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2014 | 28 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 402 | 0.020 |
Why?
|
| HIV | 1 | 2012 | 70 | 0.020 |
Why?
|
| Vaccinia virus | 1 | 2012 | 73 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 1552 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 453 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2011 | 21 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1592 | 0.020 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2011 | 12 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1991 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 333 | 0.020 |
Why?
|
| RNA, Transfer, Phe | 1 | 2010 | 3 | 0.020 |
Why?
|
| Peptide Elongation Factor Tu | 1 | 2010 | 7 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2010 | 50 | 0.020 |
Why?
|
| Codon | 1 | 2010 | 56 | 0.020 |
Why?
|
| Male | 2 | 2021 | 29889 | 0.020 |
Why?
|
| Photobleaching | 1 | 2009 | 4 | 0.020 |
Why?
|
| Chromans | 1 | 2009 | 16 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2009 | 30 | 0.020 |
Why?
|
| Benzyl Alcohols | 1 | 2009 | 28 | 0.020 |
Why?
|
| Female | 2 | 2021 | 32878 | 0.020 |
Why?
|
| Fluorescence | 1 | 2009 | 91 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 200 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2009 | 143 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2570 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 790 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 28 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 63 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 153 | 0.010 |
Why?
|
| Catalysis | 1 | 2003 | 161 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 292 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2003 | 107 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2003 | 186 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 246 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 255 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 864 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 837 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1186 | 0.010 |
Why?
|